mCig, Inc. Announces Upcoming Release of CBD/THC Pre-Loaded

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
mCig, Inc. Announces Upcoming Release of CBD/THC Pre-Loaded Disposable Vape

BEVERLY HILLS, Calif., Jan. 14, 2015 (GLOBE NEWSWIRE) -- As the market for legal medical and recreational marijuana extracts and as safer, more convenient ways of consuming them converges, mCig (OTCBB: MCIG ) today announced that it is rolling out its EM-J™, a new pre-loaded vaporizing pen thru its Colorado-based subsidiary mCig, CBD Technologies. The unique bundled product combines the highest quality THC and CBD concentrated oils pre-loaded into a convenient, discrete vaporizing pen device, which requires no flame, and produces no smoke or odor.

At the heart of the EM-J™ is a revolutionary new vaporizing liquid that uses a non-toxic thinning fluid. Incorporating a newly developed processing chamber and closed-loop extraction system, the EM-J™ is expected to replace today's conventional pens, which typically use chemicals like Propylene Glycol (PG) or Vegetable Glycerin (VG). Many users have a physical intolerance to chemical-based pens, while others have complained about a chemical-flavored after-taste when inhaling. mCig Inc. engineers have developed a much cleaner approach to vaporization thanks to a patent-pending technique within the extraction process. Versions of the EM-J™ will also be available on an OEM basis for extraction companies, growers, and dispensaries as well.   

According to Paul Rosenberg, mCig, Inc. CEO, the market for cannabis extracts is projected at $2 billion annually with expected growth to $10 billion by 2018, and the Company is well suited to become a dominant player in all aspects of the market segment. "More than any other company today, we are vertically integrated and optimized to best serve this quickly growing market. Our new line of EM-J™ vaporizer pens, along with our advanced non-toxic extraction process, extraction machines, and facilities address the most pressing needs of today's medical and recreational marijuana providers. Along with our recent investment in our CannaProTech, LLC subsidiary, operating out of Oregon, we're quickly putting the pieces together to be an industry powerhouse," explained Rosenberg.

Rosenberg also points to the Company's recently launched Colorado-based subsidiary, mCig CBD Technologies, LLC as another key initiative underscoring the company's long-term commitment to extracts. The subsidiary is responsible for designing and manufacturing a new line of products that will leverage its EM-J™ technology for delivery of Cannabis plant derivatives, largely around CBD. CBD, or Cannabidiol, is an active compound in marijuana with and a wide range of potential medical benefits and none of the psychoactive effects of THC. 

"Our investments in and around THC and CBD extracts and extract delivery systems reflects the overall growing market enthusiasm for extract-based delivery forms. This is an area we intend to lead and innovate through continued research and product development across a wide-range of consumer devices, edibles and extractions, as well as enterprise-grade equipment," added Mr. Rosenberg.

mCig, Inc. is currently in the process of repositioning itself from a dynamic vaporizer company with price-disruptive products into an umbrella holding company covering a wide spectrum of profit centers in the growing Cannabis industry. In the last year since the initial sales of the mCig 2.0 began until now, the company has sold 10's of thousands of mCig2.0/2.5 devices at disruptive price points of $10-$19. mCig, Inc. plans on continuing this trend with the recent release of the mCig 3.0 and Rick Ross Edition BO$S mCig 3.0. 

With the advent of the mCig 3.0, mCig, Inc. has delivered an innovative device that is both price disruptive and a game changer on quality at only $99 MSRP. In recent weeks, our average sales price per transaction nearly doubled thanks to the mCig 3.0 and Rick Ross BO$S devices. The company plans on releasing a slimmed down version of the mCig 3.0 in the next 30 days. The new device will be the mCig 4.0 and it will be slightly wider and longer than the mCig 2.5 with a price point of $60 or less.

The company is in negotiations with dispensary operators, tobacco chain outlets, and major distributors in the US to begin distributing and marketing these two products. With these supply lines established, mCig, Inc. plans to integrate its m$ignature Series products of high end vaporizers and consumer accessories into an array of retail channels worldwide throughout 2015. 

About mCig, Inc.

mCig, Inc. (MCIG) is a technology company focused on two long-term secular trends sweeping the globe: (1) The decriminalization and legalization of marijuana for medicinal or recreational purposes (2) The adoption of electronic vaporizing cigarettes (commonly known as "eCigs") by the world's 1.2 Billion smokers. The company manufactures and retails the mCig(R) -- the world's most affordable vaporizer priced at only $10. Designed in the USA -- the mCig(R) provides a superior smoking experience by heating plant material, waxes, and oils delivering a smoother inhalation experience. The company also owns Vapolution, Inc., which manufactures and retails home-use vaporizers such as the Vapolution 2.0. Through its 47% owned affiliate, VitaCig, Inc. the company manufactures and retails the VitaCig(R), a $5 nicotine-free eCig that delivers a water-vapor mixed with vitamins and natural flavors. The company believes that a well-regulated marijuana industry is emerging as more states follow the lead of Alaska, Colorado, Oregon, and Washington in legalizing marijuana. A similar trend is developing within the eCig industry following the first acquisition of an electronic cigarette brand (Blucigs) by a traditional tobacco company Lorillard Inc. for $135 million followed by another acquisition in February 2014 by Altria Group Inc. of Green Smoke for $150 million. Wells Fargo analyst Bonnie Herzog estimates that eCig sales may rise from $1 Billion in 2013 to $10 billion over the next three years.

mCig, Inc. (MCIG) has positioned itself as a first mover at the intersection of these two trends and hopes to create shareholder value by making the mCig(R) one of the leading choices for electronic consumption of plant material. - See more at: http://www.mcig.org/investors/investor-opportunity-subpage/

Safe Harbor Statement

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies.

Paul Rosenberg CEO 1 (310) 402-6937

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 509

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 537

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 0

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 523

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 441

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 349

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 340

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 262

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 400

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Thames Ventures VCT 1 PLC Reports Unaudited NAV for 2024

Updated Category News Views 81

Thames Ventures VCT 1 PLC Releases Unaudited NAV for 2024 Thames Ventures VCT 1 PLC has provided important updates about its financial status through its unaudited net asset value (NAV). As of June 30, 2024, the NAV stands at 45.9p per share. This announcement is significant for both the company and its investors, as understanding the NAV is essential for evaluating the...

Continue Reading
Gap Inc Achieves Impressive Growth and Market Expansion

Updated Category News Views 362

Gap Inc Reports Promising Financial Results Shares of Gap Inc (GAP) saw a significant uptick in early trading on Friday following the announcement of their latest quarterly results. This positive financial report highlighted a stronger performance than expected, showcasing the company's effective strategies and management efforts. Analysts' Positive Outlook on Gap In the...

Continue Reading
The Town Lake Company's Bold New Industrial Project Launch

Updated Category News Views 226

The Town Lake Company Initiates New Industrial Development Benchmark Business Parks, a division of The Town Lake Company, has proudly initiated construction on its latest small-bay industrial project. This significant development is located at 1433 Chris Lane and will encompass an impressive 84,200 square feet of innovative tilt-wall flex industrial space. The project is...

Continue Reading
Investors Unite in Class Action Against Everus Construction Group

Updated Category News Views 330

Opportunity for Investors in Everus Construction Group, Inc. In recent developments, investors of Everus Construction Group, Inc. (NYSE: ECG) have found themselves in the midst of a class action lawsuit that has drawn considerable attention. This lawsuit targets purchases made by investors during a specified period, raising important questions about the company's...

Continue Reading
Lam Research Board Approves Quarterly Dividend Announcement

Updated Category News Views 120

Lam Research Corporation Declares New Dividend Lam Research Corporation (Nasdaq: LRCX) has recently made an important announcement regarding its financial strategy. In their latest meeting, the company's Board of Directors approved a quarterly dividend of $0.23 per share for all common stockholders. This decision reflects Lam Research's commitment to providing value to...

Continue Reading